Alliance Foundation Trials Opens Its First Gynecological Cancer Study

October 6, 2021

The Alliance Foundation Trials, LLC (AFT), in partnership with Genentech, a member of the Roche Group, today announced the launch of the first gynecological oncology study in the AFT portfolio - AFT-50 EndoMAP [A phase IB/II umbrella study for patients with recurrent or persistent endometrial cancer]. The AFT-50 EndoMAP study will evaluate the efficacy and safety of targeted agents paired with immuno

Alliance Foundation Trials, SOLTI, Novartis launch HARMONIA, an international phase III study for selected patients with aggressive HR+/HER2- advanced breast cancer

September 17, 2021

  • HARMONIA is the first prospective phase III trial to enroll selected patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) identified using an RNA-based subtype classification
  • The trial seeks to

Research Call for Investigators - TransPALLAS

September 15, 2021

The TransPALLAS Committee today announced a Research Call for Investigators for the PALLAS study. 

The following three documents provide more details about the research call:

Trans-PALLAS Overview Research Calls for Investigators
PALLAS-Research Proposal Checklist
PALLAS-Research Project Proposal Submission Form

Older News